Michael Scolaro

Michael Scolaro

Sep 19, 2017

Group 6 Copy 146
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Developing a New Mouse Model for Studying Chemotherapeutic Nephrotoxicity

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to...

    Synthesis of a Kidney Cancer Drug

    We need to prepare a 75 mg sample of our anti-kidney cancer drug for testing. The sample was requested by...

    Mathematical model to reduce maternal and infant mortality in Southeast Asia

    Maternal and child mortality in Southeast Asian countries is still very high, especially in poor and rural...

    Backer Badge Funded